market access

News

Digital therapeutics formularies five years away in US, say ...

Payers from the US may not include digital therapeutics products on formularies for another five years, according to a report.

Events

Partner Content

Discover who’s speaking at Real-World Evidence 2020: Rare Di...

Don’t miss your chance to attend:

News

Vifor forges iron drug partnership with Fresenius in China

Vifor Pharma has forged a strategic partnership with Fresenius Kabi, focusing on marketing a portfolio of iron deficiency drugs.

News

NICE rejects MSD/Pfizer's combination in untreated kidney ca...

NICE said “no” to NHS funding for a combination of MSD’s Keytruda (pembrolizumab) immunotherapy and Pfizer’s Inlyta (axitinib) in untreated kidney cancer, citing uncertainties about its lon

News

Novartis plots cardio trial in UK as London HQ opens

Novartis has announced the beginnings of a major cardiovascular outcomes trial in the UK, as it opened a new headquarters in London.

Events

Partner Content

Real-World Evidence 2020: Rare Diseases and Innovative Thera...

Explore practical applications of RWE in rare diseases

Digital therapeutics formularies five years away in US, say ...

Discover who’s speaking at Real-World Evidence 2020: Rare Di...

Vifor forges iron drug partnership with Fresenius in China

NICE rejects MSD/Pfizer's combination in untreated kidney ca...

Novartis plots cardio trial in UK as London HQ opens

Real-World Evidence 2020: Rare Diseases and Innovative Thera...

Repligen builds in cell therapy with $1.5bn BioLife takeover

Discover a new era of healthcare panel engagement: Grounded ...

market access

Editor's Picks